N/A
N=175
Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease
ESRD
Bottom Line
View on ClinicalTrials.gov: NCT02270515 ↗Enrolled (actual)
175
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Unadjusted — 35.5; 38.4; 36.3; 36.8 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Patient-Centered Medical Home for Kidney Disease (PCMH-KD) (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Illinois at Chicago
- Primary completion
- Aug 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Unadjusted |
35.5; 38.4; 36.3; 36.8; 49.2; 50.4 | — |
| PRIMARY Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Adjusted |
35.7; 38.3; 36.0; 36.7; 48.9; 50.1 | — |
| PRIMARY Estimated KDQOL-36 Scale Score Change for Each 6-month Period and 0-18 Months: Adjusted Random-intercept Models |
2.6; -2.3; 0.7; 1.0; 1.2; 1.3 | 0.002 sig |
Summary
This study will implement and evaluate a patient-centered medical home for kidney disease (PCMH-KD) compared to the usual model of dialysis care. Patients will be observed for an initial baseline period under the usual care model and then the usual dialysis care team will be expanded to include a pharmacist, community health worker, nurse coordinator and a primary care doctor. Outcomes of interest will be assessed at baseline and then every 6 months after the PCMH-KD intervention commences.
Eligibility Criteria
Inclusion Criteria
- Current patient receiving hemodialysis at two participating dialysis centers who are able to provide informed consent
Exclusion Criteria
- Not a patient at one of the two participating dialysis centers or not able to provide informed consent
Data sourced from ClinicalTrials.gov (NCT02270515). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.